Assessment of anxiety in subclinical thyroid disorders
Assessment of anxiety in subclinical thyroid disorders
复制标题
DOI：
10.1507/endocrj.51.311
复制
发表时间：
2004-06-01
影响因子：
2
通讯作者：
Kaya, A
中科院分区：
文献类型：
--
作者：
Gönen, MS;Kisakol, G;Kaya, A
众所周知，明显的甲状腺功能障碍会导致情绪障碍。文献中很少有与亚临床甲状腺功能障碍和焦虑相关的研究。我们的目的是确定焦虑与亚临床甲状腺功能障碍之间是否存在关系。这项研究是在塞尔丘克大学梅拉姆医学院内分泌和代谢系进行的。八十五名门诊患者参加了这项研究。在存在正常 fT(3) 和 fT(4) 的情况下，患者被分为 TSH 低于 0.1 mU/L 的亚临床甲状腺功能亢进 (n = 24)、TSH 高于 4.5 mU/L 的亚临床甲状腺功能减退 (n = 32) 和甲状腺功能正常受试者 (n = 29)。对所有患者进行贝克焦虑量表（BAI）。甲状腺功能正常组和研究组在年龄、性别、体重和身高方面没有任何统计学上的显着差异（p
It is well known that manifest thyroid dysfunction causes mood disorders. In the literature there are few studies related with subclinical thyroid dysfunction and anxiety. We aimed to determine if there exists a relation between the anxiety and subclinical thyroid dysfunction. This study was carried out in the Meram Medical Faculty of Selcuk University, Department of Endocrinology and Metabolism. Eighty-five outpatients were enrolled into the study. In the presence of normal fT(3) and fT(4) patients were grouped as subclinical hyperthyroid with TSH lower than 0.1 mU/L (n = 24), subclinical hypothyroid with TSH higher than 4.5 mU/L (n = 32) and euthyroid subjects (n = 29). Beck's Anxiety Inventory (BAI) was administered to all patients. There was no any statistically significant difference between euthyroid and study groups in terms of age, gender, weight and height (p